Brief: Glaukos Announces EU MDR Certification For iStent infinite And Other Leading MIGS Therapies
25/06/2025 22:02
June 25 (Reuters) - Glaukos Corp GKOS.N: GLAUKOS ANNOUNCES EU MDR CERTIFICATION FOR ISTENT INFINITE® AND OTHER LEADING MIGS THERAPIES Source text: ID:nBw2VG8Dya Further company coverage: GKOS.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary